RET kinase inhibitor (Ocean University of China/Shanghai Institute of Materia Medica of the Chinese Academy of Sciences/Zhejiang University)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameRET kinase inhibitor (Ocean University of China/Shanghai Institute of Materia Medica of the Chinese Academy of Sciences/Zhejiang University)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase receptor RET inhibitors
TargetsTyrosine-protein kinase receptor RET
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesOcean University Of China
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesZhejiang UniversityShanghai Institute Of Materia Medica, Chinese Academy Of SciencesOcean University Of China
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A